Determining the impact of opioid policy on intended and unintended harms: a data linkage study

07/08/2023
07/08/2023
EU PAS number:
EUPAS104005
Study
Planned
Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Drug utilisation
Non-interventional study

Non-interventional study design

Cohort
Other

Non-interventional study design, other

Case-crossover
Population studied

Age groups

  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

60000
Study design details

Main study objective

Using a linked dataset, this project aims to examine if changes to opioid prescribing policies have impacted prescription opioid-related harms.

Outcomes

The main outcomes of interest are ED presentations and hospital admissions attributed to substance use (both opioid and non-opioid) or mental ill-health (e.g. suicide, self-harm, anxiety, depression). We focus on these outcomes as opioid and non-opioid-related substance use, mental health crises and suicide have all been demonstrated to be key outcomes related to changes in opioid prescribing.

Data analysis plan

This is a population linked data study using data from general practice health records obtained from the Population Level Analysis and Reporting (POLAR) platform and linked with person-level data from three large hospital networks in Victoria, Australia. Interrupted time series (ITS) will be used to examine the impact of opioid policies on a range of harms including the incidence of presentations related to substance use (opioid and non-opioid), and mental ill-health among the primary care cohort. Group-based trajectory modelling and a case-crossover design will be used to further explore the impact of changes in opioid dosage and other covariates on opioid and non-opioid poisonings, and mental ill-health related presentations at the patient-level.